ArticleScientific reports2017

Use of Biocompatible Sorafenib-gold Nanoconjugates for Reversal of Drug Resistance in Human Hepatoblatoma Cells.

Sandeep Kumar Vishwakarma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.